Search

everythinglearnresearchcommunity

for

Search:↓

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

Shift work disrupts the body's natural clock, leading to health problems.

Younger Jordanians know more about rosemary, often using it for hair and stomach issues.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Androgenetic alopecia is a common hair loss condition influenced by various factors and linked to psychosocial and cardiovascular issues.

Baricitinib helps regrow hair in severe alopecia areata but has side effects like infections and headaches.

Long COVID causes lasting symptoms and needs ongoing care.

The nutritional supplement Pilopeptan® WOMAN improved hair growth and thickness in women with hair loss.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

The document suggests a new way to categorize skin and mind disorders into two main groups to reduce confusion.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

Some types of hair loss can be reversed, others are permanent, and treatments vary by type.

Policymakers should integrate criteria like risk of harm, skills, qualifications, and teamwork to define allied health professions in Malaysia.

Patients with cutaneous lupus erythematosus have a severely impaired quality of life, especially emotionally.

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.

Passiflora incarnata may help with anxiety and sleep issues but has side effects; teleconsultation for heart failure can improve quality of life; increased screen time for children during the pandemic led to more clinical complaints; older and severely affected COVID-19 patients are more likely to have long-term symptoms.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

People with Seasonal Affective Disorder have different brain activity in certain areas when resting.

People with psoriasis and depression have lower BDNF levels, which could help measure depression in those with psoriasis.

Using 5-alpha reductase inhibitors may increase the risk of mild depression.

The two-factor model fits better for Chinese patients' understanding of illness causes than the original four-factor model.

Many young Australian women think they have PCOS, but only a few are diagnosed correctly, causing unnecessary worry.

Anorexia Nervosa and Bulimia Nervosa are complex eating disorders with increasing incidence among young females, significant morbidity, and varying mortality rates, requiring more research for better treatment.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Many women who have used performance-enhancing drugs in Finland show high rates of mental health and substance use issues, and most have normal red blood cell counts.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

Skin symptoms without a medical cause often reflect psychological stress and are influenced by culture, requiring a team approach for treatment.

The meeting discussed medical findings, including benefits of certain treatments for cancer and heart conditions, and highlighted issues like poor adherence to preventive measures and skill gaps among interns.

The study concluded that different treatments reduced post-COVID symptoms over time and that factors like age, severity, and comorbidities affect symptom risk.